"10.1371_journal.pone.0054712","plos one","2013-02-06T00:00:00Z","Ghanashyam Sarikonda; Sowbarnika Sachithanantham; Yulia Manenkova; Tinalyn Kupfer; Amanda Posgai; Clive Wasserfall; Philip Bernstein; Laura Straub; Philippe P Pagni; Darius Schneider; Teresa Rodriguez Calvo; Marilyne Coulombe; Kevan Herold; Ronald G Gill; Mark Atkinson; Gerald Nepom; Mario Ehlers; Teodora Staeva; Hideki Garren; Lawrence Steinman; Andrew C Chan; Matthias von Herrath","La Jolla Institute for Allergy and Immunology, Diabetes Center, La Jolla, California, United States of America; University of Colorado Denver, Aurora, Colorado, United States of America; University of Florida, Gainesville, Florida, United States of America; Immune Tolerance Network, San Francisco, California, United States of America; JDRF International, New York, New York, United States of America; Bayhill Therapeutics, San Mateo, California, United States of America; Stanford University, Stanford, California, United States of America; Genentech, Inc, South San Francisco, California, United States of America; Yale University, New Haven, Connecticut, United States of America; Benaroya Research Institute, Seattle, Washington, United States of America","Oversee ITN-preclinical consortium projects including initiation of projects, operations and guiding them to completion: LS PB GN TS. Conceived and designed the experiments: RG MA MvH LS AC HG. Performed the experiments: GS SS YM TK AP PP DS TRC MC. Analyzed the data: GS ME MvH. Contributed reagents/materials/analysis tools: RG MA MvH AC KH CW LS HG. Wrote the paper: GS ME MvH.","Andrew Chan is the director of research at Genentech Inc. Hideki Garren and Lawrence Steinman are founding members of Bayhill Therapeutics Inc. All other authors have declared no competing interests exist. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Ghanashyam Sarikonda","GS",22,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
